Journal of Virology & Antiviral ResearchISSN: 2324-8955

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Estimation of the Role of Apolipoprotein E Genotypes in Patient Infected with Hepatitis C Virus and Treatment with Sovaldi Drug

Background: Some single-nucleotide polymorphisms (SNPs) in lipid organizers such as apolipoproteins and cell surface molecules for hepatitis C virus (HCV) entry into hepatocytes are related to HCV infection. Silencing apoE expression resulted in marked inhibition of infectious particle production without affecting. Aim: This study aimed to investigate the effect of apoE genotype on the response to HCV treatment with sovaldi drug at Sohag governorate, Egypt. Method: Randomly, we selected 285 patients infected with hepatitis C virus from males and females with different age groups. All patients selected from Sohag governorate and treated with sovaldi drug for knowledge of the responder and non-responder for treatment by using RT-PCR technology. Results: Our results showed that out of 285 patients were infected with hepatitis C virus and treated with sovaldi drug, 258/285 (90.5%) patients were responded to treatment, and 27/285 (9.5%) patients non-responded to treatment. Out 285 patients were infected with hepatitis C virus and treated with sovaldi drug, we selected 50 patients (25 responded to sovaldi treatment and 25 non-responded to treatment) for other investigation. All patients aged between 30 to 55 years, where 13 (26%) cases of females and 37 (74%) cases of males. Our investigation showed that, in the case of respond to the treatment of Sovaldi drug, there are three genotypes of apoE ε3/ε2, ε3/ε3and ε3/ε4, which are 8 (32%), 2 (8%) and 15 (60%) respectively. In the case of non-response, there are 3 (12%) cases with ε3/ε2, 14 (56%) cases with ε3/ε3 and 8 (32%) cases with ε3/ ε4. The concentration apoE increases in the case of infection with HCV and when the non-respond to therapy, while decreased when the respond to therapy. Conclusion: This study shows the role of apolipoprotein E polymorphism on the outcome of the HCV infection after treatment with sovaldi drug. 

Special Features

Full Text


Track Your Manuscript

Media Partners